|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-1-27
|
|
pubmed:abstractText |
Thioctic acid (TA), glibenclamide and acarbose are widely used to either alone or concomitantly treat patients suffering from noninsulin-dependent diabetes (NIDDM). This study systematically investigated drug-drug interactions between TA and glibenclamide and TA and acarbose.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0306-5251
|
|
pubmed:author |
pubmed-author:BlumeH HHH,
pubmed-author:ColeL NLN,
pubmed-author:Fieger-BüschgesHH,
pubmed-author:FreudenthalerSS,
pubmed-author:GleiterC HCH,
pubmed-author:HermannRR,
pubmed-author:PotthastHH,
pubmed-author:SchneiderEE,
pubmed-author:SchreebK HKH,
pubmed-author:SchugB SBS,
pubmed-author:ThomasMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
819-25
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10594485-Acarbose,
pubmed-meshheading:10594485-Adult,
pubmed-meshheading:10594485-Blood Glucose,
pubmed-meshheading:10594485-Cross-Over Studies,
pubmed-meshheading:10594485-Drug Interactions,
pubmed-meshheading:10594485-Enzyme Inhibitors,
pubmed-meshheading:10594485-Female,
pubmed-meshheading:10594485-Glyburide,
pubmed-meshheading:10594485-Humans,
pubmed-meshheading:10594485-Hypoglycemic Agents,
pubmed-meshheading:10594485-Insulin,
pubmed-meshheading:10594485-Male,
pubmed-meshheading:10594485-Thioctic Acid
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Lack of interaction between thioctic acid, glibenclamide and acarbose.
|
|
pubmed:affiliation |
Abteilung Klinische Pharmakologie, Universität Göttingen, Göttingen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
